🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.

Some experts said the popularity for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or prison.

Service Response and Material Removal

According to TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The company stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

After minutes of joining one group, a seller posted WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Information and Costs

Inside these groups, messages display black plastic packages with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.